In 2007, supplementation with the trace element selenium in a trial was unexpectedly found to be associated with an excess risk of type 2 diabetes. Given the concerns raised by these findings and the large number of recent studies on this topic, we reviewed the available literature with respect to this possible association. In this paper, we assessed the results of both experimental and nonexperimental epidemiologic studies linking selenium with type 2 diabetes incidence. Through a systematic literature search, we retrieved 50 potentially eligible nonexperimental studies and 5 randomized controlled trials published through June 11, 2018. To elucidate the possible dose-response relation, we selected for further analysis those studies that included multiple exposure levels and serum or plasma levels. We computed a pooled summary risk ratio (RR) of diabetes according to selenium exposure in these studies. We also computed a RR for diabetes incidence following supplementation with 200 µg/day of selenium compared with placebo in trials. In the nonexperimental studies, we found a direct relation between selenium exposure and risk of diabetes, with a clear and roughly linear trend in subjects with higher plasma or serum selenium levels, with RR at 140 µg/L of selenium exposure compared with a referent category of < 45 µg/L equal to 3.6 [95% confidence interval (CI) 1.4-9.4]. A dose-response meta-analysis focusing on studies with direct assessment of dietary selenium intake showed a similar trend. In experimental studies, selenium supplementation increased the risk of diabetes by 11% (RR 1.11, 95% CI 1.01-1.22) compared with the placebo-allocated participants, with a higher RR in women than in men. Overall, results from both nonexperimental and experimental studies indicate that selenium may increase the risk of type 2 diabetes across a wide range of exposure levels. The relative increase in risk is small but of possible public health importance because of the high incidence of diabetes and the ubiquity of selenium exposure.

译文

:2007年,在一项试验中意外发现补充微量元素硒与2型糖尿病的过高风险有关。鉴于这些发现引起的关注以及有关该主题的大量近期研究,我们就有关这种可能的关联的文献进行了综述。在本文中,我们评估了将硒与2型糖尿病发病率相关的实验和非实验流行病学研究的结果。通过系统的文献搜索,我们检索了截至2018年6月11日发表的50项可能合格的非实验研究和5项随机对照试验。为阐明可能的剂量反应关系,我们选择进行了进一步分析的研究包括多重暴露水平以及血清或血浆水平。在这些研究中,我们根据硒的摄入量计算了汇总的糖尿病汇总风险比(RR)。我们还计算了与安慰剂相比,补充200 µg /天的硒后,糖尿病发病率的RR。在非实验性研究中,我们发现硒暴露与糖尿病风险之间存在直接关系,血浆或血清硒水平较高的受试者中硒的暴露与参考类别相比RR为140 µg / L,呈明显且大致线性的趋势<45 µg / L等于3.6 [95%置信区间(CI)1.4-9.4]。着重于直接评估膳食硒摄入量的研究的剂量反应荟萃分析显示了相似的趋势。在实验研究中,与安慰剂分配的参与者相比,补充硒使患糖尿病的风险增加11%(RR 1.11,95%CI 1.01-1.22),女性的RR高于男性。总体而言,非实验研究和实验研究的结果均表明,硒可能会在广泛的暴露水平下增加2型糖尿病的风险。风险的相对增加很小,但由于糖尿病的高发和硒暴露的普遍存在,对公共卫生可能具有重要意义。

+1
+2
100研值 100研值 ¥99课程
检索文献一次
下载文献一次

去下载>

成功解锁2个技能,为你点赞

《SCI写作十大必备语法》
解决你的SCI语法难题!

技能熟练度+1

视频课《玩转文献检索》
让你成为检索达人!

恭喜完成新手挑战

手机微信扫一扫,添加好友领取

免费领《Endnote文献管理工具+教程》

微信扫码, 免费领取

手机登录

获取验证码
登录